Cointime

扫码下载App
iOS & Android

Biohaven Pharmaceutical

company
Exit Type
M&A
Exit Date
May 5, 2017

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Litmore Capital Post-IPO Equity Detail
Knoll Capital Management Series Unknown Detail